FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013524192> ?p ?o ?g. }

• W2013524192 endingPage "21" @default.
• W2013524192 startingPage "15" @default.
• W2013524192 abstract "Many pediatric patients undergoing cardiac surgery involving cardiopulmonary bypass have a predictable fall in the cardiac index 6 to 18 hours after surgery, the so-called low cardiac output syndrome (LCOS). Because patients who have LCOS require more monitoring and support and have a prolonged stay in the intensive care unit, the syndrome is associated with a costly morbidity. Milrinone, a phosphodiesterase III inhibitor, improves cardiac muscle contractile force and vascular muscle relaxation through positive inotropic and vasodilatory effects. The purpose of the Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics (PRIMACORP) study is to evaluate the safety and efficacy of the prophylactic use of milrinone in pediatric patients at high risk for development of LCOS after undergoing cardiac surgery.Patients in the multicenter, randomized, double-blind, placebo-controlled, parallel treatment study will be randomized to 1 of 3 treatment arms: (1) low-dose milrinone (25 microg/kg intravenous bolus over 60 minutes followed by a 0.25 microg/kg/min infusion for 35 hours), (2) high-dose milrinone (75 microg/kg intravenous bolus over 60 minutes followed by a 0.75 microg/kg/min infusion for 35 hours), or (3) placebo.The primary end point for efficacy evaluation will be based on a composite variable consisting of death or development of LCOS requiring additional mechanical or pharmacologic support, up to 36 hours after randomization. A 2-sided test with a 0.025 type I error will be used for the primary end point analysis. The PRIMACORP study will enroll a total of 240 patients. Six additional secondary end points will be analyzed.The PRIMACORP study will address several questions regarding the safety and efficacy of prophylactic milrinone use in pediatric patients at high risk for development of LCOS after cardiac surgery." @default.
• W2013524192 created "2016-06-24" @default.
• W2013524192 creator A5000903403 @default.
• W2013524192 creator A5045579094 @default.
• W2013524192 creator A5049162285 @default.
• W2013524192 creator A5049945885 @default.
• W2013524192 creator A5054355203 @default.
• W2013524192 creator A5061425487 @default.
• W2013524192 creator A5062478612 @default.
• W2013524192 creator A5086298145 @default.
• W2013524192 creator A5087303107 @default.
• W2013524192 creator A5087634407 @default.
• W2013524192 creator A5088209830 @default.
• W2013524192 date "2002-01-01" @default.
• W2013524192 modified "2023-10-05" @default.
• W2013524192 title "Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study" @default.
• W2013524192 cites W157233602 @default.
• W2013524192 cites W1967354447 @default.
• W2013524192 cites W2001400624 @default.
• W2013524192 cites W2040395293 @default.
• W2013524192 cites W2049966366 @default.
• W2013524192 cites W2058700103 @default.
• W2013524192 cites W2058813030 @default.
• W2013524192 cites W2059529621 @default.
• W2013524192 cites W2059707463 @default.
• W2013524192 cites W2065775430 @default.
• W2013524192 cites W2069516636 @default.
• W2013524192 cites W2075584178 @default.
• W2013524192 cites W2079406923 @default.
• W2013524192 cites W2092424825 @default.
• W2013524192 cites W2122971191 @default.
• W2013524192 cites W2138373808 @default.
• W2013524192 cites W2150050635 @default.
• W2013524192 cites W2319534362 @default.
• W2013524192 cites W2615136647 @default.
• W2013524192 cites W4242589154 @default.
• W2013524192 doi "https://doi.org/10.1067/mhj.2002.120305" @default.
• W2013524192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11773907" @default.
• W2013524192 hasPublicationYear "2002" @default.
• W2013524192 type Work @default.
• W2013524192 sameAs 2013524192 @default.
• W2013524192 citedByCount "139" @default.
• W2013524192 countsByYear W20135241922012 @default.
• W2013524192 countsByYear W20135241922013 @default.
• W2013524192 countsByYear W20135241922014 @default.
• W2013524192 countsByYear W20135241922015 @default.
• W2013524192 countsByYear W20135241922016 @default.
• W2013524192 countsByYear W20135241922017 @default.
• W2013524192 countsByYear W20135241922018 @default.
• W2013524192 countsByYear W20135241922019 @default.
• W2013524192 countsByYear W20135241922020 @default.
• W2013524192 countsByYear W20135241922021 @default.
• W2013524192 countsByYear W20135241922022 @default.
• W2013524192 countsByYear W20135241922023 @default.
• W2013524192 crossrefType "journal-article" @default.
• W2013524192 hasAuthorship W2013524192A5000903403 @default.
• W2013524192 hasAuthorship W2013524192A5045579094 @default.
• W2013524192 hasAuthorship W2013524192A5049162285 @default.
• W2013524192 hasAuthorship W2013524192A5049945885 @default.
• W2013524192 hasAuthorship W2013524192A5054355203 @default.
• W2013524192 hasAuthorship W2013524192A5061425487 @default.
• W2013524192 hasAuthorship W2013524192A5062478612 @default.
• W2013524192 hasAuthorship W2013524192A5086298145 @default.
• W2013524192 hasAuthorship W2013524192A5087303107 @default.
• W2013524192 hasAuthorship W2013524192A5087634407 @default.
• W2013524192 hasAuthorship W2013524192A5088209830 @default.
• W2013524192 hasConcept C139940330 @default.
• W2013524192 hasConcept C141071460 @default.
• W2013524192 hasConcept C168563851 @default.
• W2013524192 hasConcept C178853913 @default.
• W2013524192 hasConcept C203092338 @default.
• W2013524192 hasConcept C2776645727 @default.
• W2013524192 hasConcept C2778789114 @default.
• W2013524192 hasConcept C2778881276 @default.
• W2013524192 hasConcept C31861589 @default.
• W2013524192 hasConcept C42219234 @default.
• W2013524192 hasConcept C43376680 @default.
• W2013524192 hasConcept C71924100 @default.
• W2013524192 hasConceptScore W2013524192C139940330 @default.
• W2013524192 hasConceptScore W2013524192C141071460 @default.
• W2013524192 hasConceptScore W2013524192C168563851 @default.
• W2013524192 hasConceptScore W2013524192C178853913 @default.
• W2013524192 hasConceptScore W2013524192C203092338 @default.
• W2013524192 hasConceptScore W2013524192C2776645727 @default.
• W2013524192 hasConceptScore W2013524192C2778789114 @default.
• W2013524192 hasConceptScore W2013524192C2778881276 @default.
• W2013524192 hasConceptScore W2013524192C31861589 @default.
• W2013524192 hasConceptScore W2013524192C42219234 @default.
• W2013524192 hasConceptScore W2013524192C43376680 @default.
• W2013524192 hasConceptScore W2013524192C71924100 @default.
• W2013524192 hasIssue "1" @default.
• W2013524192 hasLocation W20135241921 @default.
• W2013524192 hasLocation W20135241922 @default.
• W2013524192 hasOpenAccess W2013524192 @default.
• W2013524192 hasPrimaryLocation W20135241921 @default.
• W2013524192 hasRelatedWork W1978904368 @default.
• W2013524192 hasRelatedWork W2061463574 @default.
• W2013524192 hasRelatedWork W2068895154 @default.

• next